Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.22 USD | +26.15% | +23.87% | -8.25% |
05-14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.25% | 191M | |
+30.04% | 454B | |
+25.40% | 264B | |
+7.50% | 136B | |
+34.35% | 95.88B | |
+7.24% | 93.13B | |
+59.75% | 57.75B | |
+16.58% | 46.89B | |
+27.88% | 38.33B | |
+1.95% | 35.84B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- Lake Street Adjusts OptimizeRx Price Target to $76 From $98, Maintains Buy Rating